Research

The Karnovsky Lab's research involves the analysis of high throughout omics data, focusing primarily on metabolomics, and the development of computational methods and tools for the analysis and integration of metabolomics data with other types of genomic data. The lab is also interested in biomedical ontologies and one of my current projects involves the development of Informed Consent Ontology.

Alla Karnovsky's background includes Ph.D. in cell and developmental biology (Russian Academy of Sciences), postdoctoral work at the University of Colorado at Boulder and nine years of bioinformatics work in Pharmaceutical industry (at Pharmacia and at Pfizer). Alla has broad experience in identification and validation of therapeutic targets in variety of disease areas including antibacterials, CNS and dermatology. She is also interested in structural aspects of drug/target interactions and the integration of chemical and genomic domains.